News By Tag
News By Location
ImmunoReagents Enters Distributorship Agreement with Abyntek Biopharma of Spain
ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced Abyntek Biopharma as its new distributor in Spain.
ImmunoReagents and Abyntek will partner to distribute top quality antibodies and reagents to the Spanish biotech, life science, and medical communities. According to the 2009 Industrial Biotechnology in Spain report, “Spain contributes an estimated 4% of the world’s biotech-related scientific production, ranking 4th in the EU-15.” The majority of the research is being conducted in food, human and animal health industries. From the latest ASEBIO report, there are over 1,500 Spanish biotech companies with over 12,500 employees. These facts show the sheer importance of conducting business in Spain.
"We are very excited to be working with Abyntek." said Ann Black, President and CEO of ImmunoReagents. "Our partnership with Abyntek will bring our highly regarded products to the thriving Spanish biotech market.”
ImmunoReagents is a leading global manufacturer of quality polyclonal antibodies and reagents used in research and in vitro diagnostics. They offer a wide range of secondary antibodies covering a broad spectrum of immunoglobulins from various species. Antibodies include various levels of cross species absorptions to provide high specificity. The Company also manufactures primary polyclonal antibodies to hormones, cancer markers, cardiac markers and serum proteins. In addition to its vast product lines, ImmunoReagents also provides custom manufacturing to meet specific customer requirements while adhering to cGMP guidelines and ISO quality systems requirements. The Company is located on NCSU’s Centennial Campus, the University-owned and operated research park and technology campus.
More information about ImmunoReagents:
Founded in 2006, Abyntek Biopharma S.L. is a private Spanish company aimed at supplying antibodies and providing personalized antibody manufacturing services. Abyntek distributes a comprehensive catalogue of more than 250,000 antibodies and proteins. They are the leading Spanish provider of in-house monoclonal and polyclonal antibody development. They also offer antibody modifications such as biotinylation or conjugation to fluorophores and enzymes. In addition, Abyntek offers full development of ELISA tests.
More information about Abyntek: www.abyntek.com